These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 2909265)
21. 'Is this treatment worth while?' How to read the medical journals. Rheeder P; Ker JA S Afr Med J; 2000 Jan; 90(1):37-9. PubMed ID: 10721386 [No Abstract] [Full Text] [Related]
22. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation]. Algra A; van der Graaf Y Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260 [TBL] [Abstract][Full Text] [Related]
24. Blinding in pharmacological trials: the devil is in the details. Wan M; Orlu-Gul M; Legay H; Tuleu C Arch Dis Child; 2013 Sep; 98(9):656-9. PubMed ID: 23898156 [No Abstract] [Full Text] [Related]
28. Quality and reporting of trial design in scientific papers in Anaesthesia over 25 years. Langford RA; Huang GH; Leslie K Anaesthesia; 2009 Jan; 64(1):60-4. PubMed ID: 19032695 [TBL] [Abstract][Full Text] [Related]
29. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study. James KE; Bloch DA; Lee KK; Kraemer HC; Fuller RK Stat Med; 1996 Jul; 15(13):1421-34. PubMed ID: 8841652 [TBL] [Abstract][Full Text] [Related]
30. [Double-blind or open mind?]. Huttunen JK Duodecim; 1986; 102(16):1129-33. PubMed ID: 3757849 [No Abstract] [Full Text] [Related]
31. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations]. Dorhout Mees EJ Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2228. PubMed ID: 11103264 [No Abstract] [Full Text] [Related]
32. Assessment of blinding in clinical trials. Bang H; Ni L; Davis CE Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033 [TBL] [Abstract][Full Text] [Related]
33. Antiemetic studies: a methodological discussion. Olver IN; Simon RM; Aisner J Cancer Treat Rep; 1986 May; 70(5):555-63. PubMed ID: 3708607 [TBL] [Abstract][Full Text] [Related]
34. A critique of the double-blind clinical trial. Part 2. Kiene H Altern Ther Health Med; 1996 Mar; 2(2):59-64. PubMed ID: 8795890 [TBL] [Abstract][Full Text] [Related]
36. [Multiple practice research. Experience with some methods]. Bennedsen H; Nielsen JV Ugeskr Laeger; 1979 May; 141(22):1482-4. PubMed ID: 377745 [No Abstract] [Full Text] [Related]
37. Grading clinical research: a midterm report card. Schechter MT; Sheps SB Can Med Assoc J; 1984 Nov; 131(9):1025-7. PubMed ID: 6498714 [No Abstract] [Full Text] [Related]
38. [Summary of the podium discussion on the fundamentals and guidelines for preliminary clinical trials of psychopharmaceutics (phase I and II) Oct. 29, 1977]. Heimann H Arzneimittelforschung; 1978; 28(9):1534-6. PubMed ID: 383105 [No Abstract] [Full Text] [Related]
39. Dose selection and comparator drugs in schizophrenia research. Kane JM J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828 [TBL] [Abstract][Full Text] [Related]